Altenative Medicines Baltimore, MD - 21202

Altenative Medicines is categorized under Health Practitioners in Baltimore, MD and active since 1997.

Altenative Medicines was established in 1997, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Health Practitioners business, which does work in the B2B market, and is classified as a Health Practitioners, under code number 6213993 by the NAICS.

If you are seeking more information, feel free to contact E Mimi Palenque, Manager at the company’s single location by writing to 12 East Mount Vernon Place Apartment 302, Baltimore, Maryland MD 21202 or by phoning (410) 230-0886. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Altenative Medicines
Contact Person: E Mimi Palenque, Manager
Address: 12 East Mount Vernon Place Apartment 302, Baltimore, Maryland 21202
Phone Number: (410) 230-0886
Annual Revenue (USD): $100.000 to $499.999
Founded: 1997
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Health Practitioners
SIC Code: 8049
NAICS Code: 6213993
Share This Business:

Altenative Medicines was started in 1997 to provide professional Health Practitioners under the SIC code 8049 and NAICS code 6213993. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact E Mimi Palenque, Manager for inquiries that concern Altenative Medicines by calling the company number (410) 230-0886, as your correspondence is most welcome. Additionally, the physical location of the single location of Altenative Medicines can be found at the coordinates 39.297892,-76.615609 as well as the street address 12 East Mount Vernon Place Apartment 302 in Baltimore, Maryland 21202.

For its online presence, you may visit Altenative Medicines’s website at and engage with its social media outlets through on Twitter and on Facebook.